NeuroPred, Inc.
PrivateLast Round
Grant
Nov 5, 2025
Total Funding Raised
$105,000
Company Overview
NeuroPred, Inc. is a healthcare AI company that provides an AI-powered software platform that converts clinical MRI scans into stroke diagnoses and cognitive outcome predictions.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroPred, Inc. Comps
Public and private peers based on sector, stage, and business model.
NeuroPred, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 5, 2025 | ||||
| Debt | Sep 19, 2025 | ||||
| Grant | Apr 18, 2024 |
NeuroPred, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Iowa John Pappajohn Entrepreneurial Center | Grant |
| Iowa Economic Development Authority | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 5, 2025
$50K grant received from Amazon Web Services.
- Sep 19, 2025
$50K raised from Iowa Economic Development Authority.
NeuroPred, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroPred, Inc.'s valuation, stock price, and market status.